ABT vs EDUC · P/E 25, rev $44.33B vs P/E 5.4, rev $22.9M
Abbott Laboratories (ABT) versus Educational Development Corporation (EDUC) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Educational Development Corporation (EDUC) is a publishing company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported EDUC revenue for 2026-02-28 was $22.9M. Net income was $2.3M. Revenue was up 245.3% from 2025-02-28 to 2026-02-28. EDUC currently screens at market cap $12.3M and trailing P/E 5.4.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. EDUC currently screens at market cap $12.3M and trailing P/E 5.4.
Not investment advice. Open the ABT and EDUC stock pages for the full models.
Not investment advice.